Lance Alstodt, President, CEO, COB at BioRestorative Therapies, Inc. (BRTX), bought 1,470 shares at $3.40 ($5K) on 2022-01-24, disclosed to the SEC on 2022-01-24.
Open-market purchase of $5k BRTX by President, CEO, COB. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BRTX | BUY | 2023-09-06 | $6K | — | Filing → |
| BRTX | BUY | 2023-07-25 | $10K | — | Filing → |
| BRTX | BUY | 2023-02-02 | $1K | — | Filing → |